Last Updated on June 13, 2025 by The Health Master
Allergy
Seasonal allergies affect millions at various times during the spring. Between fluctuating temperatures and unexpected snowstorms, sneezing and itchy eyes are rampant. It’s common for people to pop allergy medicine from over the counter available for preventative use, at least for symptom relief, to avoid intrusive symptoms in their everyday life.
USFDA allergy warning
A recent USFDA allergy warning suggests they might NOT need to recover from a hidden disaster: a shocking and life-changing itching side effect (pruritus) that occurs upon the discontinuation of some of the most well-known allergy medicines.
We’re not talking about an inconvenience here; this is a side effect that has sidelined people, and some have even ended up in the hospital.
Allergy Treatment
The US Food and Drug Administration (USFDA) has issued a severity association between popular antihistamine medicines and a shocking active side effect.
According to the USFDA, hundreds of individuals who used these allergy drugs consistently for extended periods stopped using them and found themselves in unexpected situations: itching—intense itching that was so bad that these individuals needed to go to the hospital.
Fact
The fact that this itching occurs in connection with stopping a drug designed to stop itching is paradoxical and of great concern.
The reports indicate that the only way to stop the itching is to resume taking allergy medicines, worsening the previously unacknowledged dependency issue on such a large scale.
Itching
Most people find itching merely annoying; the USFDA reports on this itching are far worse than anything someone can complain about.
Imagine not being able to work, relax at home with family, or fall asleep because of itching so badly. Forget about productivity; effective quality of life goes down the drain.
USFDA Revises Medicine Guidelines
The USFDA intends to amend its prescribing and usage recommendations for these particular allergy medicines based on its observations/goals from the study.
This is reassuring for those who fear using aging allergy medicines down the line.
Scare tactics change over time for a reason, and organizations involved in pharmacovigilance know how to syndicate data through appropriate means to make proper downward recommendations.
Q. Which allergy medicines cause this severe itching?
The USFDA uses terms like “very popular allergy medicines” and “such drugs” in general without specifying active ingredients or brand names in public. Consult your physician to see if your allergy medicine is part of this general classification.
Q. Is this a typical side effect of all allergy medicines?
No. The USFDA has observed this significant itching (pruritus) only in those patients who had been taking the popular allergy medication for a long time and then stopped. This is not a commonly expected side effect for all allergy medicines or as a rapid withdrawal symptom for those who use it for a few days.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
Delhi High Court: Cough Syrup Warning Labels Now Required
USFDA issues Warning Letter to Granules India over these Deficiencies
FSSAI: Food Labelling and Display – Chapter-18
42 Companies banned over supply of NSQ drugs: Rajasthan
83,090 Tablets of Alprazolam and Zolpidem Seized, 1 Arrested
High Salicylic Acid: India Halts Cosmetic Imports
Drug alert: 196 drug samples declared as NSQ in April 2025
Key Notes on Revised Schedule M: API Part-5
Bengaluru Gears Up for the 74th IPC 2025 with a Focus on AI & Innovation
USFDA inspection: At Reddy’s at New York API plant with 2 observations
